Related Experiment Video
Updated: Apr 28, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells
Jürgen Sonnemann1, Maite Hartwig, Andrea Plath
1Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Ernst Moritz Arndt University, Greifswald, Germany.
Abstract:
Histone deacetylase inhibitors (HDIs) are a promising new class of antineoplastic agents with the capacity to induce growth arrest and/or apoptosis of cancer cells. However, their precise mechanism of action is uncertain; particularly, the role of caspases in the apoptotic response to HDIs is controversial. Here, we show that the HDIs explored, suberoylanilide hydroxamic acid, sodium butyrate and trichostatin A, activated caspase-3 in A549 and PC-3 carcinoma cells. Additionally, the poly-caspase inhibitor z-VAD-fmk prevented HDI-induced apoptosis, as judged by determining mitochondrial membrane potential and by quantifying internucleosomal DNA fragmentation. Importantly, z-VAD-fmk also significantly inhibited HDI-elicited cell death, as assessed by measuring propidium iodide uptake. As an accessory finding, with the inhibition of caspases, a HDI-induced G2-M arrest became evident. Taken together, these results provide evidence that HDIs require activated caspases to induce apoptosis of carcinoma cells.
Insights
Histone deacetylase inhibitors (HDIs) activate caspases to induce cancer cell death. Blocking caspases with z-VAD-fmk prevents HDI-driven apoptosis and reveals cell cycle arrest, clarifying HDI mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Histone deacetylase inhibitors (HDIs) are investigated as antineoplastic agents.
- The precise mechanism of action for HDIs, especially the role of caspases in apoptosis, remains controversial.
Purpose of the Study:
- To investigate the role of caspases in HDI-induced apoptosis in carcinoma cells.
- To elucidate the mechanism by which HDIs trigger cancer cell death.
Main Methods:
- Treatment of A549 and PC-3 carcinoma cells with HDIs (suberoylanilide hydroxamic acid, sodium butyrate, trichostatin A).
- Assessment of apoptosis via mitochondrial membrane potential and DNA fragmentation.
- Inhibition of caspases using the poly-caspase inhibitor z-VAD-fmk.
- Quantification of cell death using propidium iodide uptake.
- Cell cycle analysis to evaluate cell cycle arrest.
Main Results:
- HDIs activated caspase-3 in A549 and PC-3 cells.
- z-VAD-fmk inhibited HDI-induced apoptosis, mitochondrial membrane potential loss, DNA fragmentation, and cell death.
- Caspase inhibition unmasked a G2-M cell cycle arrest in response to HDIs.
Conclusions:
- Activated caspases are required for HDIs to induce apoptosis in carcinoma cells.
- HDIs trigger cancer cell death through a caspase-dependent pathway.
- Caspase inhibition reveals an alternative HDI-induced cell cycle arrest mechanism.
Related Concept Videos
Anaphase Promoting Complex
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

